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A B S T R A C T   
Personality is associated consistently with mortality hazards, but the physiological pathways are not yet clear. 
Immune system dysregulation may be one such pathway due to its role in age-related morbidity and mortality. In 
this preregistered study, we tested whether interleukin-6 (IL-6) and C-reactive protein (CRP) mediated the as-
sociations between personality traits and mortality hazards. The sample included 957 participants (M ± SD =
58.65 ± 11.51 years; range = 35–86 years) from the Midlife in the United States Survey that had 14 years of 
follow-up. Higher conscientiousness was associated with lower mortality hazards, with each one standard de-
viation higher conscientiousness associated with a 35% lower mortality risk. IL-6, but not CRP, partially 
mediated this association, with IL-6 accounting for 18% of this association in the fully adjusted model. While 
there was initial evidence that the biomarkers mediated both neuroticism and agreeableness and mortality risk, 
the indirect effects were not significant when controlling for the sociodemographic variables. Taken together, 
higher conscientiousness may lead to a longer life partially as a result of lower IL-6. This work highlights the 
importance of biological pathways that link personality to future mortality risk.   
1. Introduction 
Personality traits, as operationalized by the Five Factor Model (FFM; 
also referred to as the “Big Five”), have been linked consistently to long- 
term health outcomes, including mortality (Roberts et al., 2007). Robust 
evidence indicates that higher conscientiousness – a tendency to be 
responsible, organized, and capable of self-control – is associated with 
lower risk of mortality (Graham et al., 2017; Jokela et al., 2013). Low 
scores of this trait, for example, are associated with an approximately 
40% increased risk of mortality over an average of six years of follow-up 
(Jokela et al., 2013). In contrast, neuroticism – a tendency to experience 
more negative emotions such as fear and sadness – tends to be associated 
with elevated mortality risk (Graham et al., 2017), also across long 
follow-up periods in very old age (O’Súilleabháin and Hughes, 2018). 
However, protective effects for neuroticism and mortality risk have also 
been reported (Weiss and Costa, 2005). The evidence has been more 
mixed for the remaining personality traits within the FFM (e.g. Mroczek 
and Spiro, 2007; Ferguson and Bibby, 2012; O’Súilleabháin and Hughes, 
2018). The consistent evidence that personality, particularly conscien-
tiousness, is associated with mortality has led to great interest in iden-
tifying the pathways that explain this association. 
Stemming from developmental psychology (Baltes and Goulet, 
1970), the lifespan perspective is one that provides considerable ave-
nues to view the possible ways that personality may impact mortality 
risk across the life course. As discussed by Hampson and Friedman 
(2008), both the critical period models (whereby exposure to risk during 
critical periods have longer-lasting effects than at other times) and 
accumulation models (impact of exposures to risk accumulates across 
the lifespan) have been well suited to examine personality and health 
associations. Most work on the possible pathways that contribute to the 
relation between personality and long-term mortality risk has focused 
on health-related behaviors (Friedman et al., 1995; Mroczek et al., 2009; 
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Turiano et al., 2015, 2012; Graham et al, 2017). Notably absent from 
this existing literature is the direct examination of underlying physio-
logical mechanisms that may contribute to the predictive effect of per-
sonality on mortality risk. 
Decades of research have established the importance of the complex 
structure of the immune system in health processes across the lifespan. 
Two markers, cytokine interleukin 6 (IL-6) and the acute phase protein 
C-reactive protein (CRP) are central to the immune system. Both of these 
biomarkers are historically thought of in the context of inflammation 
that involves the body’s defences in responding to actual or potential 
infections. However, recent research has highlighted the breadth of 
processes beyond inflammation that both IL-6 and CRP are related to 
which are also critically important to health across the lifespan (Del 
Giudice and Gangestad, 2018). Both of these biomarkers have been 
regularly implicated as critical to disease-specific and all-cause mortal-
ity (Li, H. et al., 2017, Li, Y. et al., 2017; Proctor et al., 2015; Emerging 
Risk Factors Collaboration, 2010). These biomarkers outperform tradi-
tional health risk prediction methods such as the Framingham Risk Score 
(DeFilippis et al., 2015) and are linked to the onset and development of 
chronic illnesses (Netea et al., 2017; Vasto et al., 2007). 
Over the last decade, the idea that personality traits are associated 
with both IL-6 and CRP has received growing interest (Sutin et al., 2010; 
Luchetti et al., 2014). Evidence suggests that conscientiousness may 
have a protective role in inflammatory-related biomarkers (Luchetti 
et al., 2014; see also Allen and Laborde, 2017; Sutin et al., 2018; Elliot 
et al., 2017; Turiano et al., 2013; Wagner et al., 2019). For example, 
Luchetti and colleagues (2014) found higher conscientiousness to be 
associated with lower CRP across three large, US samples (N > 26,000): 
For each 1SD higher conscientiousness, the risk of exceeding the clinical 
threshold of CRP (≥3 mg/l) was lowered by 10–15% across the samples. 
These results were also supported by a meta-analysis of published studies 
on both CRP (7 studies) and IL-6 (6 studies) where conscientiousness 
was negatively associated with both of the biomarkers (estimated r was 
− 0.05 for CRP and − 0.08 for IL-6; Luchetti et al., 2014). In addition to 
conscientiousness, the meta-analysis found a negative correlation be-
tween openness and CRP and no significant associations for extraversion 
or agreeableness (Luchetti et al., 2014). Higher neuroticism has been 
associated with higher levels of IL-6 (Sutin et al., 2010), but this asso-
ciation did not replicate in the meta-analysis (see Luchetti et al., 2014). 
Later studies have mostly supported the association between conscien-
tiousness and lower inflammation; the findings for the other traits 
remain mixed (see Allen and Laborde, 2017; Wagner et al., 2019, 
Hengartner et al., 2016; Israel et al., 2014; Graham et al., 2018). 
Much of the literature to date on the mechanisms between person-
ality and mortality has examined behavioural pathways, with little 
research examining potential physiological pathways. Some literature 
has also examined the associations between personality and indices of 
biomarkers, including allostatic load, and have speculated that physio-
logical dysregulation is one pathway that links personality to poor 
health outcomes (Stephan et al., 2016). The research that has considered 
the physiological pathways are either theoretical or solely examine the 
association between personality and specific biomarkers, not whether 
these biomarkers mediate the relation between personality and mor-
tality. In this preregistered study, we addressed whether circulating 
levels of biomarkers could be an underlying mechanism through which 
personality is associated with mortality risk. Specifically, this research 
investigated if IL-6 and CRP provide a pathway linking personality and 
mortality risk over a period of 14 years. This study focused on IL-6 and 
CRP due to their role in age-related morbidity and mortality and their 
reported associations within the existing literature on personality and 
biomarkers. It was hypothesised that both biomarkers would mediate 
associations of both conscientiousness and neuroticism with mortality 
risks. For extraversion, openness, and agreeableness, we hypothesized 




Preregistration and related documents for this study are available at 
https://osf.io/263sf. The data used within this study are publicly 
available through the Inter-University Consortium for Political and So-
cial Research (ICPSR). All analyses were conducted in accordance with 
the preregistration. 
2.2. Participants 
Data for this study were from the Midlife in the United States 
(MIDUS) study that had started in 1995 with 7,108 noninstitutionalized 
adults between the ages of 25 and 75 years (Brim et al., 2019). The first 
follow-up (MIDUS 2) was between 2004 and 2006 with 4,963 partici-
pants (Ryff et al., 2017). A subset of these participants took part in a 
biomarker study (N = 1255; Ryff et al., 2019). Each participant was 
invited to attend a clinical research center for a comprehensive exami-
nation by trained medical staff that included the collection of biological 
specimens, a thorough physical exam, and the recording of medical 
history data (Ryff et al., 2019). Of the available sample with IL-6 and 
CRP data (n = 1,235), some participants did not complete the person-
ality assessment (n = 199) or provide medication data (n = 79). As such, 
the present sample included 957 adults (M ± SD = 58.62 ± 11.50 years, 
range: 35 – 86; females, M ± SD = 57.87 ± 11.27 years, range: 35 – 86; 
males, M ± SD = 59.58 ± 11.74 years, range: 36–85). All protocols re-
ported within this study were granted full ethical approval as part of the 
MIDUS 2 Biomarker Project, in accordance with the Declaration of 
Helsinki. 
An attrition analysis previously reported by Graham and colleagues 
(2018) found that those who did not complete the biomarker project 
were higher in neuroticism, lower in openness to experience, less 
educated, less healthy, and more likely to be white. 
Compared to participants deceased during the follow-up, partici-
pants who were alive on the final update were younger (t = − 12.43, p <
0.001, 95% CI [− 15.52, − 11.29]), more likely to be female (χ2 = 10.81, 
p = 0.001), higher in conscientiousness (t = 2.99, p = 0.003, 95% CI 
[0.045, 0.22]), had lower levels of difficulty in completing activities of 
daily living (t = − 3.20, p = 0.002, 95% CI [− 0.36, − 0.09]), lower levels 
of logIL-6 (t = -6.03, p < 0.001, 95% CI [− 0.25, − 0.13]), and did not use 
oral non-steroidal anti-inflammatory medication (χ2 = 13.01, p < 0.001) 
at baseline (see Table 1). 
2.3. Measures 
2.3.1. Mortality 
Vital status was determined and collated through several methods 
(National Death Index (NDI), closeout interviews, and during longitu-
dinal sample maintenance), with the most recent update in October 
2018. Because only month and year of death were available for each 
deceased participant, they were assigned the 15th day of the month as 
their exact date of death (Turiano et al., 2015). There were 111 deaths 
across the follow-up (M ± SD = 137.15 ± 26.86 months; range =
6–171); 846 participants were reported as alive on their most recent 
update. Time was defined as the number of months between the date of 
the MIDUS 2 Biomarker assessment and date of death. 
2.3.2. Personality 
Personality traits were assessed using the Midlife Development In-
ventory (MIDI) Personality Scales (Lachman and Weaver, 1997). Par-
ticipants indicated the extent to which 26 adjectives described them on a 
4-point Likert scale ranging from 1 “not at all” to 4 “a lot”. Items for each 
personality traits are as follows: Neuroticism (moody, worrying, ner-
vous, calm [reverse]), Extraversion (outgoing, friendly, lively, active, 
talkative), Openness to Experience (creative, imaginative, intellect, 
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curious, broad-minded, sophisticated, adventurous), Conscientiousness 
(organized, responsible, hardworking, thorough, careless [reverse]), 
and Agreeableness (helpful, warm, caring, softhearted, sympathetic). 
McDonald omegas for each personality trait are as follows (McDonald, 
1999): Neuroticism (ωt = 0.74), Extraversion (ωt = 0.79), Openness to 
Experience (ωt = 0.77), Conscientiousness (ωt = 0.73), Agreeableness 
(ωt = 0.82). Cronbach’s α levels were all greater than 0.68. 
2.3.3. Inflammatory markers 
Blood samples were collated at three examination sites (University of 
California, Los Angeles (UCLA); Georgetown University; University of 
Wisconsin). Serum IL-6 was measured using a high-sensitivity enzyme- 
linked immunosorbent assay (ELISA; R & D Systems). High-sensitivity 
CRP was assessed via plasma with a particle enhanced immunonepho-
lometric assay (BNII nephelometer from Dade Dehring). IL-6 was 
assayed in the MIDUS Biocore Laboratory (University of Wisconsin, 
Madison). CRP was assayed at the Laboratory for Clinical Biochemistry 
Research (University of Vermont). Intra and inter-assay coefficients of 
variance were in the acceptable range for both inflammatory markers; 
IL-6 (3.25, 12.31%), and CRP (4.4%, 5.7%). See Ryff and colleagues 
(2019) for more details about the biomarker assessment. 
2.3.4. Confounding variables 
The following variables were included as covariates (each measured 
at the biomarker clinic visit): age; sex (male, female); race (white, 
other); education (highest level of education “attained ranging from no 
schooling or some grade school” to “professional degrees such as PhD or MD”; 
smoking (ever smoker versus non-smoker); chronic conditions (total 
number of doctor-diagnosed medical conditions; e.g., hypertension, 
heart disease, diabetes, cancer, stroke); and activities of daily living 
(ADL; the extent to which health impacts their ability to perform ten 
activities (e.g. bathing, dressing) ranging from “not at all” to “a lot”). 
Comprehensive information on medication use was also collated as part 
of the biomarker project. Each participant was required to bring all their 
medications to the clinic visit in the original containers, such that 
medication names and dosages were accurately recorded. Information 
pertaining to medications were then linked to generic names and cor-
responding drug IDs via linkage to the Lexi-Data database, which were 
then linked to their therapeutic and pharmacologic class codes. For this 
study, any form of corticosteroid (encompassing inhalant, nasal, 
ophthalmic, otic, rectal, systemic, and topical) medications were 
dummy coded (no, yes). Both oral and parenteral non-steroidal anti- 
inflammatory medication (NSAID) were also included as further cova-
riates (no, yes). 
The full correlation table of all variables is available in the supple-
mentary materials. Each covariate was selected given they have been 
repeatedly implicated as critically important in the context of the vari-
ables under direct examination within this present study (e.g. National 
Institutes of Health, 2020; Cutler and Lleras-Muney, 2006; O’Súil-
leabháin et al., 2019, 2020; Levine et al., 1993). 
2.4. Analyses 
Statistical analyses were conducted using Mplus Version 8 (Muthén 
and Muthén, 2020). Cox Proportional Hazards Model was used to esti-
mate the risk of death to consider time-to-event including those reported 
as alive (censored). While allowing for direct and indirect effects on 
survival time, a structural equation model framework was utilised to 
estimate mediation in Cox proportional hazards (Asparouhov et al., 
2006). All confidence intervals (CI) are reporting 95% thresholds. To 
statistically test inflammation as an indirect pathway in the predictive 
effect of personality for mortality hazards, models included IL-6 and CRP 
simultaneously as mediators. As outlined previously (Turiano et al., 
2015), this approach is critical as it allows for the assessment of both 
mediators together as their combined indirect effect may significantly 
explain the association between personality and mortality. This 
approach also incorporates the correlations between indirect effects 
(Preacher and Hayes, 2008; Turiano et al., 2015). 
A base-10 logarithm transformation was performed on both IL-6 and 
CRP variables to reduce skewed distributions. CRP levels above 10 mg/L 
may reflect current infection. These observations (n = 29) were retained 
in the present analysis to provide superior estimates of associations 
(Moriarity et al., 2021), in addition to the retention of outcome variance 
that is meaningful (O’Connor et al., 2009). Main analyses were con-
ducted both with and without those observations to determine if esti-
mates changed. Results did not differ. Examination of chronic conditions 
revealed a number of extreme outlier observations (n = 6). Winsorizing 
was employed to limit the number of chronic conditions to 6 which was 
deemed to represent the closest observation not deemed suspect (Tukey, 
1962). To ensure winsorization did not alter estimates significantly, 
main analyses were conducted with chronic conditions winsorized at 
both 5 and 7. Results did not differ. To determine if lag in time (defined 
as the length of time between when the psychometric and biological 
data were collated; M ± SD = 25.94 ± 14.67 months; range = 0–61) 
could be an important confounding factor, analyses were conducted 
both with and without controlling for it. Results did not differ. As such, 
and in line with this variable not being formally included within the 
preregistration of this study, it was not included as a possible con-
founding variable. Personality traits were standardized for ease of 
interpretation, such that associations with personality reflected a dif-
ference of one standard deviation. Assessment of Schoenfeld residuals 
for IL-6 revealed a potential violation of the assumption of proportion-
ality. In accordance with the interaction method when a potential 
violation of the assumption occurs (Allison, 2010), we included an 
interaction term of IL-6 and months to death as a covariate for IL-6. 
Prior to examining mediation, each variable was assessed as a pre-
dictor of mortality. Model 1 tested the effects of personality traits 
collectively for mortality. Model 2 included sociodemographic factors 
(age, sex, race, education). Model 3 included health-related confounders 
(smoking, chronic conditions, activity of daily living, corticosteroid 
medication, oral NSAID, and parenteral NSAID). Model 4 included both 
IL-6 and CRP. Following these initial models, a series of models then 
tested whether the biomarkers mediated this pathway. Specifically, 
Model 5 examined both biomarker mediation pathways for each per-
sonality trait on mortality, with mortality, IL-6, and CRP adjusted for the 
remaining personality traits not under direct examination. Similar to the 
Table 1 






(n = 957)  
Mean (SD)/% Mean (SD)/ 
% 
Mean (SD)/% 
IL-6 (pg/mL)* 4.23 (4.18) 2.63 (2.57) 2.82 (2.85) 
CRP (ug/mL)* 3.73 (7.37) 2.63 (3.79) 2.76 (4.37) 
Neuroticism 1.95 (0.61) 2.05 (0.63) 2.04 (0.63) 
Extraversion 3.11 (0.60) 3.13 (0.57) 3.13 (0.57) 
Openness to Experience 2.97 (0.52) 2.96 (0.52) 2.96 (0.52) 
Agreeableness 3.41 (0.48) 3.44 (0.50) 3.44 (0.50) 
Conscientiousness 3.35 (0.47) 3.49 (0.43) 3.47 (0.44) 
Age (years) 70.61 (11.44) 57.09 
(10.57) 
58.65 (11.51) 
Sex (Female) 41.4% 57.9% 56% 
Race (White) 96.4% 92.9% 93.3% 
Education 7.63 (2.49) 7.78 (2.46) 7.76 (2.46) 
Chronic Conditions 1.18 (1.26) 0.99 (1.29) 1.01 (1.29) 
ADL 1.41 (0.71) 1.18 (0.49) 1.21 (0.53) 
Smoking (no) 42.3% 57.7% 55.9% 
Corticosteroid 
Medication (no) 
82% 87.9% 87.3% 
NSAID Oral (no) 33.3% 51.5% 49.4% 
NSAID Parenteral (no) 88.3% 86.6% 86.8% 
Note: * = prior to transformation, ADL = activities of daily living, higher values 
of ADL refer to greater difficulty in performing activities. 
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first set of analyses, Model 6 adjusted for age, sex, race, and education 
and Model 7 further adjusted for smoking, chronic conditions, activity of 
daily living, corticosteroid medication, oral NSAID, and parenteral 
NSAID. 
3. Results 
Several baseline variables had a direct effect on mortality (see 
Table 2). Consistent with previous analyses of earlier follow-up periods 
in MIDUS (Graham et al., 2017), Conscientiousness was associated lower 
mortality risk (HR = 0.74; p = 0.001; 95% CI, 0.61–0.87), such that each 
1 SD increase in conscientiousness was associated with a 35% reduced 
risk of mortality. This effect was attenuated with the introduction of 
demographic controls (HR = 0.80; p = 0.028; 95% CI, 0.64–0.96) and 
the health-related factors (HR = 0.81; p = 0.038; 95% CI, 0.65–0.97). 
The association, however, was reduced to non-significance when 
adjusted for IL-6 and CRP in Model 4 (HR = 0.83; p = 0.080; 95% CI, 
0.66–1.00). No other personality trait was associated with mortality. In 
the fully adjusted baseline model, IL-6 was associated with greater 
mortality risk (HR = 2.99; p = 0.010; 95% CI, 0.49 – 5.49). There was no 
significant association for CRP (HR = 0.91; p = 0.733; 95% CI, 0.42 – 
1.40). Of the remaining predictors within the fully adjusted baseline 
model, age (HR = 1.10; p < 0.001; 95% CI, 1.08–1.13) and ADLs (HR =
1.33; p = 0.043; 95% CI, 0.96–1.70) were associated with greater 
mortality risk. 
Each personality trait was examined for the potential that IL-6 and 
CRP may mediate between it and mortality because mediation does not 
require a direct effect from the predictor to outcome variable (Preacher 
et al., 2007). The combined indirect effects of both biomarkers were a 
significant indirect pathway between conscientiousness and mortality 
risk (Table 3). IL-6 emerged as a robust mediator of the association 
between conscientiousness and mortality in each model: Model 5 (p =
0.001), Model 6 (p = 0.028), and Model 7 (p = 0.032)1. These significant 
mediation results across models accounted for an estimated 23.46%, 
18.47%, and 17.65% of the effect of conscientiousness on mortality 
through IL-6, respectively (see Table 3). No significant indirect effect for 
CRP was observed. There was some evidence of an indirect pathway 
from neuroticism and agreeableness to mortality through IL-6 in Model 
5, but neither indirect effect remained significant with the sociodemo-
graphic adjustments. There was no significant effect for extraversion or 
openness. See supplementary tables for all mediation results for extra-
version, openness, and agreeableness. While it was not included in the 
preregistration of this manuscript, we also did an exploratory test for an 
interaction between neuroticism and conscientiousness on its associa-
tion with IL-6 and mortality. No significant association emerged. 
4. Discussion 
We found support for our preregistered hypotheses: Both IL-6 and 
CRP were an indirect path that partially linked conscientiousness to 
mortality risk. Examination of both IL-6 and CRP revealed that IL-6 was 
the significant contributor to this mediating effect. As such, higher 
conscientiousness was found to be associated with a longer life partially 
as a result of lower IL-6. Contrary to our preregistered hypothesis, we 
did not find that CRP itself was a significant mediator. Although there 
was some initial evidence that the biomarkers mediated both neuroti-
cism and agreeableness and mortality, the indirect effects were not 
significant when controlling for the sociodemographic variables. 
Finally, as expected, the biomarkers did not mediate either extraversion 
or openness and mortality risk. 
The conscientiousness findings are critically important because they 
Table 2 
Proportional hazards models predicting mortality.   







































































































































































































AIC 1670.022 1524.160 1513.580 1429.542 
BIC 1694.315 1567.840 1586.253 1516.729 
Note: HR = Hazard Ratio, AIC = Akaike Information Criterion, BIC = Bayesian 
Information Criterion. 
1 This fully adjusted significant finding remained virtually unchanged for 
conscientiousness whether or not the remaining personality traits were adjusted 
for within the model. 
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directly link a biomarker as a pathway from a personality trait to mor-
tality risk. The importance of IL-6 to physical and cognitive health 
processes across the lifespan is well established. IL-6 is one of the main 
inflammatory components associated with age-related pathologies 
(Franceschi and Campisi, 2014), including central nervous system dis-
eases (Erta et al., 2012), cardiovascular disease (Fontes et al., 2015), and 
also in the allocation of energetic resources and nutrients relevant to 
adipose tissue (Del Giudice and Gangestad, 2018). Both genetic and 
epidemiological research point to dysregulation in the immune system 
as a common pathway involved in the leading causes of deaths. Simi-
larly, conscientiousness has been associated with a large spectrum of 
health-related behaviours (Graham et al., 2020), age-related pathologies 
(Terracciano and Sutin, 2019), coping processes (Sesker et al., 2016), 
and weight trajectories across the lifespan (Sutin et al., 2011). The IL-6 
mediated effect of conscientiousness on mortality is likely not just a 
function of a single or small number of specific health associations but 
may permeate immunity and associated physiological systems (e.g., 
nervous, cardiovascular, respiratory, and endocrine systems). Given its 
link to morbidity and mortality, IL-6 is likely to be a key modulator 
between conscientiousness and health outcomes. 
Importantly, several avenues that link IL-6 to the etiology of disease 
across the life span have previously been linked to conscientiousness 
(Furman et al., 2019). For instance, conscientiousness has been linked to 
a wide array of health-related behaviours (Bogg and Roberts, 2004; 
Turiano et al., 2015; Sutin et al., 2011; Graham et al., 2018) with 
beneficial behavioral and clinical markers that are linked with IL-6, such 
as moderate alcohol use, less unhealthy eating, minimal drug use, and 
smoking, healthier weight, and more physical activity. Also outlined by 
Furman and colleagues (2019), IL-6 is known to have a critical role 
across physiological systems in response to stress. The role of personality 
within the context of physiological stress processes have been docu-
mented, not just as an averaged response to a single stress exposure 
(Gallagher et al., 2018), but also a pattern of responsivity across time 
during a stressful experience (O’Súilleabháin et al., 2019a), and changes 
in stress (O’Súilleabháin et al., 2019b). Research examining conscien-
tiousness and the complexity of stress responsivity is quite limited. Of 
note, however, is that many of these behavioral, clinical and biological 
factors are modifiable and thus suggest pathways that can be intervened 
upon. 
Given the role of negative emotionality in health (Lahey, 2009), we 
hypothesized that these immunity markers may also be a pathway be-
tween neuroticism and mortality. However, following full adjustment 
for possible confounding variables, no significant associations were 
found for neuroticism. Despite our interest in neuroticism, the null 
findings are perhaps not surprising given that previous studies have 
reported mixed evidence of associations between neuroticism and in-
flammatory markers (Luchetti et al., 2014). In addition, it is also 
apparent that the associations between neuroticism, health, and mor-
tality are quite nuanced (see Weiss and Deary, 2020; Graham et al., 
2020; O’Súilleabháin et al., 2019). 
There are theoretical and practical implications of this research. 
Theoretical models of personality and health have typically focused on 
behavioral mechanisms (Turiano et al., 2015); this research identified 
and provided evidence for a biological pathway. Work on personality 
and mortality suggests that psychological factors may be helpful to 
identify who is at most risk for premature mortality and why. It will be 
important in future work to test the usefulness of personality-informed 
interventions to improve health outcomes, including reducing the risk 
of premature mortality. Indeed, while the present study had several 
strengths, such as an extensive follow-up period and a variety of data 
forms representing known predictors of all-cause mortality. Limitations 
should also be noted. While this study focused specifically on both IL-6 
and CRP, further research is required to examine other potentially 
relevant pro- and anti- inflammatory cytokines, and importantly, how 
the present findings may interact with other cytokines, hormones, and 
other biomarkers as the mediating pathway is likely to be complex. The 
Table 3 
Mediation models for conscientiousness and neuroticism predicting mortality.   
Conscientiousness Neuroticism  
IL-6 CRP IL-6 CRP  
Estimate/HR, 
[95% CI], p 
Estimate/HR, 
[95% CI], p 
Estimate/HR, 
[95% CI], p 
Estimate/HR, 
[95% CI], p 








































0.771, [0.633, 0.908], 0.004 0.874, [0.684, 1.064], 0.225 
AIC 3472.824 3472.824 
BIC 3579.689 3579.689 


































− 0.041, [− 0.074, − 0.008], 0.016 − 0.016, [− 0.040, 0.008], 0.181 
Direct 
effect4,* 
0.835, [0.663, 1.006], 0.084 1.163, [0.910, 1.416], 0.173 
AIC 5962.820 5891.291 
BIC 6156.910 6085.381 


































− 0.036, [− 0.068, − 0.004], 0.028 − 0.027, [− 0.056, 0.002], 0.069 
Direct 
effect4,* 
0.833, [0.663, 1.003], 0.080 1.133, [0.873, 1.392], 0.287 
AIC 5888.771 5815.731 
BIC 6169.708 6096.668     
Note: HR = Hazard Ratio, AIC = Akaike Information Criterion, BIC = Bayesian 
Information Criterion. 
Model 5 adjusts for the remaining personality traits not under direct examina-
tion. 
Model 6 in addition to the previous adjustment, Model 5 adjusts for age, sex, 
race, education. 
Model 7 in addition to confounding variables in Model 5 and 6, adjusts for 
chronic conditions, ADL, smoking, corticosteroid medication, oral NSAID, and 
parenteral NSAID. 
^ indicates that the estimate is presented. 
* indicates that the HR is presented. 
1 Effect of personality on mortality through the indirect inflammation path. 
2 Effect of the indirect inflammation path and direct path of the personality 
trait on mortality. 
3 Sum of the indirect paths. 
4 Direct effect of the personality trait on mortality. 
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present sample is not a nationally representative sample, and as such, 
these findings require replication across a diverse range of populations. 
Additionally, while the personality measure available within the present 
study demonstrates adequate reliability, this study would have benefited 
from a more comprehensive personality scale that measured underlying 
personality facets. Facets would provide a more fine-grained examina-
tion of personality associations, which may be particularly important in 
the context of conscientiousness and biological health indices (Sutin 
et al., 2018). Given number of events is a critical component in terms of 
statistical power when computing a cox regression, a limitation with the 
present study design is that <12% of the sample had died. While there 
are challenges with inferring cause of death due to complexity with 
comorbidities at the end of life, it may be worthwhile to examine cause- 
specific mortality within larger samples to determine if specific causes 
are responsible for the association within the present study. 
To conclude, our results indicate that individuals higher in consci-
entiousness live longer in part because of lower circulating levels of IL-6. 
These results provide a critical insight into biological mechanisms that 
link this personality trait to longevity. In doing so, we highlight the 
importance and need to identify biological pathways that bridge this 
link from personality to future mortality risk for future work. This study 
provides a crucial piece to the personality-health puzzle in suggesting 
that the biomarker IL-6, which is at the core of inflammatory and aging 
processes, provides a pathway which partly explains why conscien-
tiousness is associated with long-term mortality risk. 
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